The effect of platelet depletion on the unanesthetized sheep's pulmonary response to endotoxemia was studied in eight unanesthetized sheep. Platelets were depleted with rabbit anti-sheep platelet antibodies (APA). Bolus injections of APA alone caused marked pulmonary hypertension (PPA increased from 21±2 to 62±5 cm H20 ±SE) and alterations in lung mechanics (dynamic compliance of the lung [Cdy,,] decreased to 38.5±4.6% and resistance to air flow across the lung [RU increased to 705±162%±SE of control), which were attenuated by pretreatment with meclofenamate. It was possible to deplete platelets before endotoxemia through a slow continuous infusion of APA without altering base-line values of the measured variables. Platelet depletion did not significantly attenuate the alterations in pulmonary hemodynamics, lung mechanics, lung fluid and solute exchange, or the normal increase in lung lymph concentrations of thromboxane B2 or 6-keto-PGF,. observed following endotoxemia in the sheep. We conclude that normal circulating platelet counts are not required for the full expression of the sheep's response to endotoxemia.
Introduction
The experiments described here were designed to test the hypothesis that normal circulating platelet counts are required for the full expression of the sheep's response to endotoxemia. Platelets were depleted with rabbit anti-sheep platelet antibodies (APA).' Since the antibodies themselves can cause dramatic changes in pulmonary hemodynamics and lung mechanics, alterations similar to those observed early following endotoxemia (1) (2) (3) , the effects of APA alone, were also studied.
Endotoxemia has been used, in the unanesthetized sheep, as an animal model of the adult respiratory distress syndrome (ARDS) (1) (2) (3) . Various interventions such as cyclooxygenase inhibition (1) , corticosteroids (4) , and granulocyte depletion (5, 6) alter one or more aspect of the response to endotoxemia. Platelets are a potentially rich source of agents, such as thromboxane A2, which may mediate part of the sheep's response to endotoxemia (7) (8) (9) (10) (11) (12) (13) (14) . A role for platelets has been proposed in the lung injury observed following hemorrhagic shock (12) , glass bead microembolism (11) , complement activation (8) , oleic acid (13) , as well as endotoxemia (13, 14) , and in ARDS in man (7) (8) (9) (10) (11) (12) (13) (14) . Experimental evidence from glass bead microembolization ( 11) and complement activation (8) argues against a pathogenetically important role for platelets in these types of lung injury. The pulmonary sequestration of platelets observed in hemorrhagic shock may be due to decreased pulmonary blood flow (10) , while, in oleic acid lung injury, pulmonary entrapment of platelets was unrelated to changes in physiologic dead space, pulmonary vascular resistance, or compliance (13) . The authors suggest that pulmonary platelet entrapment may cause endothelial damage (13) . Studies with platelet depletion and endotoxin shock in dogs suggest a possible role for platelets only in the early pulmonary hypertension and increased pulmonary vascular resistance observed following endotoxemia (14) .
Bolus injections of APA cause marked changes in pulmonary hemodynamics and lung mechanics in the current series of experiments. These changes, like the early alterations oW served following endotoxemia (1, 15) , were attenuated by cyclooxygenase inhibition. When platelets were depleted by a slow infusion of APA to minimize changes in lung function, platelet depletion did not attenuate the sheep's response to endotoxemia. Normal circulating platelet counts are not necessary for the full expression of the sheep's response to endotoxemia.
Methods

Sheep preparation
Yearling sheep were instrumented as previously described (1, 16) . Through a left thoracotomy, catheters were placed directly into the left atrium and pulmonary artery. Catheters were passed from the neck into the vena cava and the thoracic aorta. A thermal dilution Swan-Ganz catheter was passed through the external jugular vein into the pulmonary artery for measuring cardiac output using an Edwards model 9520A Thermodilution Cardiac Output Computer (Edwards Laboratory, Santa Ana, CA). Through a right thoracotomy, a silastic catheter was placed in the efferent lymph duct emerging from the caudal mediastinal lymph node. The tail of the caudal mediastinal lymph node was resected below the inferior pulmonary ligaments through a second right-sided thoracotomy. An additional left thoracotomy was performed to disrupt systemic lymph vessels running across the left hemidiaphragm and entering the caudal mediastinal lymph node, causing systemic contamination of the lung lymph (17) . A similar disruption was performed on the right hemidiaphragm when the tail of the caudal mediastinal lymph node was resected. At the time of the right thoracotomy, a silastic envelope was placed in the pleural space for the measurement of pleural pressure. This rectangular envelope measured 4 X 3 cm and was constructed from silastic sheeting, and a silastic catheter (internal diam, 0.157 cm) extended from within the silastic envelope. A tracheostomy was performed and a size 10 Shiley-cuffed tracheostomy tube inserted. Sheep were allowed to recover for several days following surgery.
Lung mechanics
Awake sheep were studied while standing in a specially constructed whole-body pressure-compensated integrated-flow plethysmograph. The sheep's tracheostomy tube was connected to an external valve via flexible noncollapsible tubing. This permitted the animal to move without interfering with measurements. A loosely fitting sling was placed under the sheep to prevent it from lying while in the plethysmograph. A constant bias flow was used to reduce the effective deadspace of the tubing. Tidal volume (V) was measured by pressure compensating the integrated signal from the plethysmographic pressure transducer. Flow (V) was obtained by electrically differentiating the volume signal. Airway opening pressure (P..) was measured by a multiple side hole catheter positioned 0.5 cm past the distal end of the tracheostomy tube. Pleural pressure (Pp.) was measured directly from the silastic catheter and envelope in the pleural space. Transpulmonary pressure (Ptp) was the pressure difference between Pp. and P.o. All pressure signals were measured using Validyne pressure transducers and amplification equipment (Validyne Engineering Corp., Northridge, CA). The signals from pressure transducers, catheters, and silastic envelope were tuned to eliminate phasic distortion to 20 Hz. These methods have been described in detail elsewhere (1, 6) .
Before each set of measurements of lung mechanics, the sheep's lungs were inflated to 40 cm H20 airway opening pressure using the bias flow and an occluded airway. Simultaneous V/V and V/Pp curves were then recorded during spontaneous respiration on a Tektronix dual beam storage oscilloscope and photographed for calculation of dynamic compliance of the lung (Cdyn) and resistance to air flow across the lung (RL)-Cdyn was calculated as V divided by Pp, at points of zero flow and expressed in liter per centimeter H20 at body temperature pressure standard. RL was calculated using the method of von Neergaard and Wirz (18) by dividing PFp by V at midtidal volume and was expressed as centimeters H20 per liter per second at body temperature pressure standard. Functional residual capacity (FRC) was measured using the Boyle's law method of DuBois et al. (19) . The airway was manually obstructed at end expiration. The sheep continued to make respiratory efforts against the obstruction for one to three breaths and a graph of the change in plethysmographic volume against the change in Pao was traced on the oscilloscope and photographed for calculation of FRC. Specific conductance, SGL, was calculated by dividing the reciprocal of resistance to air flow across the lung (RL) (conductance) by FRC and expressed as seconds per centimeter H20 at body temperature pressure standard.
Thromboxane B2 (TxB2) and prostacyclin metabolites binding of the label. The binding reaction continued for 60 min at 37°C and was terminated by precipitation of the immune complexes with ammonium sulfate at a final concentration of 50% of saturation.
After centrifugation at 2,500 g at 4°C for 10 min, 300 Ml of supernatant were counted in Aquasol (New England Nuclear). Each sample was assayed in duplicate, and duplicate determinations differed by <10%. The detection limit of both assays was <20% pg.
Other variables
Pulmonary artery pressure (PPA), left atrial pressure (Ph.), and aortic pressure (Pa) were continuously monitored using Hewlett Packard Model 1208C pressure transducers (Hewlett Packard Co., Palo Alto, CA). Pulmonary vascular resistance (PVR) was calculated by subtracting P,. from PPA and dividing by cardiac output. Lung lymph was collected continuously with flow determined for each 15-min interval and samples of lymph and blood were collected every 0.5 h for measurement of total proteins. Total protein concentrations in lung lymph and blood plasma were measured by a modified biuret method (20) with an automated system (AutoAnalyzer, Technicon Instruments Corp., Tarrytown, NY). Lymph protein clearance (CLp) was calculated by multiplying the lymph flow by the lymph-to-plasma protein concentration ratio. Arterial blood samples were collected every 0.5 h anaerobically during steady state base-line conditions and experimental periods and Po2, Pco2, and pH were measured using an Instrumentation Laboratories (Lexington, MA) model 513 blood gas analyzer. The alveolar-to-arterial oxygen difference (AAaPO2) on room air was calculated using the alveolar gas equation with a fixed respiratory exchange ratio of 0.8. Lung mechanics were measured every 15 min except during the first hour following endotoxemia when they were measured every 7.5 min. Leukocyte counts were done every 0.5 h on an automated system (Coulter Counter Model ZBI, Coulter Electronics, Hialeah, FL) and confirmed manually using an Unopette no. 5855 dilution system (Becton-Dickinson, Rutherford, NJ) and hemocytometer. Differential counts were done on Wright's stained smears. Platelet counts were done manually.
Rabbit APA
Rabbit APA was prepared as previously described (9, 21) . 60 ml of citrated sheep blood were centrifuged at 190 g for 40 min. The supernatant platelet-rich plasma was removed and centrifuged at 1,200 g for 20 min. The pellet was then suspended in 3 ml of a solution of 0.75 g/100 cm3 NH4Cl. The mixture was agitated, and 10 ml of 0.9% NaCl and 1.0 ml of 3.8 g/100 ml sodium citrate were added to the mixture. This mixture was centrifuged at 1200g for 20 min. The resulting pellet was washed in the saline/citrate solution and centrifuged at 1200 g for 20 min three additional times. The final pellet was resuspended in 0.9% NaCl and then microscopically examined for purity of its platelet content. Any observation of erythrocytes or leukocytes in the counting chamber caused rejection of the batch. Accepted batches were divided into 0.5-ml aliquots. Each aliquot was mixed with 0.5 ml Freund's adjuvant and injected subcutaneously into rabbits each week for 6 wk. Complete adjuvant was used for the first week only, and then incomplete adjuvant was employed for the subsequent five injections. 1 wk following the sixth injection, rabbit serum was collected and incubated at 570C for 30 min to inactivate complement. This serum was then absorbed to sheep erythrocytes, washed in citrated saline, and stored frozen in 2-ml aliquots. Control serum was obtained from rabbits and prepared as above. The appropriate serum was thawed, diluted to 50 ml in 0.9% NaCl, and filtered through a 40-,gm filter to prepare for infusion.
Experimental protocols
Bolus APA. The effects of APA alone were studied in five unanesthetized yearling sheep weighing between 35 and 45 kg. All variables were followed for a minimum of 1 h before injecting a 0.5-ml bolus of APA intraarterially. All variables were then followed for the ensuing 2 h. Sodium meclofenamate powder (Warner Lambert: Parke-Davis Pharmaceutical Div., Ann Arbor, MI) was dissolved in sterile saline (10 mg/ml) and infused intravenously at 5 mg/kg over 0.5 h followed by 3 mg/kg X h for an additional 2.5 h via a Harvard Apparatus Co. (S. Natick, MA) constant infusion pump. Three sheep were studied first with bolus APA alone. After 2 or 3 d, these three sheep were restudied after pretreatment with meclofenamate. A 0.5-ml bolus of APA was injected after the first hour of meclofenmate infusion and the variables were followed for the ensuing 2 h. After an additional 2-3 d, these three sheep were restudied a third time with bolus APA in the identical manner employed in the first study. Two sheep were studied first with meclofenamate and APA and then restudied 3 d later with APA alone.
Platelet depletion and endotoxin. Eight unanesthetized yearling sheep weighing between 35 and 45 kg were studied. The identical protocol was used in the control endotoxin experiments and in the platelet depletion and endotoxin experiments, except that control rabbit serum was infused in the former and APA in the latter. After a I h base line, either control serum or APA was infused into the aorta via a Harvard Apparatus continuous infusion pump. The infusion was begun at a rate of 0.04 ml/h and gradually increased to 20.7 ml/h. When APA was infused in this manner, platelet depletion (<5,000 platelets/mm3) was accomplished without as dramatic alterations in pulmonary hemodynamics, lung mechanics, and lung fluid and solute exchange as were observed following bolus APA. Once platelet counts were <5,000 platelets/mm3, the infusion rate was decreased to 2.1 ml/ h and maintained at this rate for the remainder of the experiment. After 4-8 h of continuous APA infusion, all variables had returned to within 10% of the original base-line values. In the control APA infusion experiments, the infusion was continued for the ensuing 5 h. The APA infusion was also continued in the platelet depletion and endotoxin experiments, except endotoxin was infused in the identical dose and manner employed in the endotoxin alone experiments Escherichia coli endotoxin (Difco Laboratory lot 3123-25 prepared by the Westphal method from E. coli 055:B5) was infused intravenously as 0.38±0.03 ,qg/kg±SE over 0.5 h. All variables were followed for the ensuing 5 h.
Four sheep were studied first with endotoxin alone followed by the platelet depletion and endotoxin experiments and control APA infusion experiments. An additional four sheep were studied first with platelet depletion and endotoxin and control APA infusion before the endotoxin alone experiments. 3 d were allowed between experiments.
Statistics
The effects of APA and endotoxin over time were studied using twoway analyses of variance (22) and comparisons made between studies using the nonparametric Wilcoxon-signed rank test and paired t-test when appropriate (23) . Statistical analyses were performed using only paired data from the same animals. P <0.05 was considered significant.
Results
Bolus APA. Bolus APA caused marked changes in pulmonary hemodynamics and lung mechanics. These changes are summarized in Table I . Pulmonary artery pressure, PPA, increased from 21±2 to 62±5 cm H20 ±SE, and PVR from 2.52±0.23 to 6.76±0.69 cm H20 -liter-' -min-' ±SE at 4 min after bolus APA. AAaPO2 increased from 17±7 to 42±16 at 4 min and 39±19 torr ±SE at 30 min after bolus APA. CdYn decreased from 0.065±0.006 to 0.025±0.003 at 4 min and 0.032±0.004 liter/cm H20 ±SE at 30 min after bolus APA. RL increased from 0.40±0.11 to 2.82±0.65 at 4 min and 6.72±1.50 cm H20 -liter-' -s-' ±SE at 30 min after bolus APA. Leukocyte counts were unaffected by bolus APA, but platelet counts decreased from 636,000±113,000 to 250,000±44,000 at 4 min and 158,000±49,000 cells/mm3 ±SE at 120 min after bolus APA. Blood TxB2 concentrations increased from 0.122±0.017 to 8.348±1.467 ng/ml ±SE at 15 min after bolus APA, while 6-keto-PGF,a increased from 0.039±0.017 to 0.191±0.089 ng/ml ±SE at 15 min after bolus APA.
Meclofenamate and bolus APA. Meclofenamate itself had no effect on any of the measured variables or on the de- .g CL crease in platelet counts observed following bolus APA (636,000±113,000 to 250,000±44,000 at 4 min and 158,000±49,000 at 120 min after bolus APA alone and from 742,000±75,000 to 279,000+130,000 and 158,000±82,000 cells/mm3 ±SE at 4 and 120 min after meclofenamate and bolus APA). Meclofenamate did attenuate the increases in blood TxB2 and 6-keto-PGFIa as well as the alterations in Pp1., PVR, and AAaPO2 at 4 min and the alterations in Cdyn i RL, and SGL at 4 and 30 min after bolus APA. These results are summarized in Table I . Platelet depletion and endotoxemia. In these experiments, endotoxemia caused changes in pulmonary hemodynamics, lung mechanics, lung fluid and solute exchange, and lung lymph concentrations of TxB2 and 6-keto-PGFia similar to those reported previously (1, 6) . In the control endotoxin experiments, endotoxin was infused in the presence of control rabbit serum. The control rabbit serum was infused in the identical manner as the rabbit APA. In the control endotoxin experiments, platelet counts were 709,000±107,000 cells/mm3 before endotoxin infusion. Endotoxemia had no significant effect on platelet counts in the control endotoxin experiments or when the sheep were studied after platelet depletion. In the platelet depletion and endotoxin experiments, platelet counts were 1,875±479 cells/mm3 before endotoxin infusion. After 4-8 h of continuous APA infusion, all measured variables had returned to within 10% of the original pre-APA values. The pre-endotoxin values of all measured variables (except platelets) were not significantly different in the control endotoxin and the platelet depletion and endotoxin experiments. In the control APA infusion experiments in which APA was infused for 5 h after platelet depletion and no endotoxin was given, the measured variables did not change. These results are shown in Figs. 1-4 .
Platelet depletion did not significantly attenuate the alterations caused by endotoxemia. Leukocytes fell to 1,240±160 cells/mm3 at 1 h after endotoxemia in the control endotoxin experiments and to 992±330 cells/mm3 ±SE in the platelet depletion and endotoxin experiments (P > 0.05) (Fig. 1) . The alterations in absolute lymphocyte and granulocyte counts were similar in the two groups of experiments. PPA increased to 52.0±6.1 cm H20 in the endotoxin control experiments and to 51.6±4.9 cm H20 ±SE in the platelet depletion and endotoxin experiments at 1 h after endotoxemia (P > 0.05) (Fig. 2) . PVR increased to 8.40±0.59 cm H20-liter-' -min-' in the endotoxin control experiments and to 10.33±1.60 cm H20-liter-' *min-±SE at 1 h after endotoxemia in the platelet depletion and endotoxin experiments (P > 0.05) (Fig.   2 ). AAaPO2 increased to 44±6 at 1 h and 44±7 at 5 h after endotoxemia in the control endotoxin experiments and to 50±8 and 46±10 torr ±SE in the platelet depletion and endotoxin experiments (P > 0.05) (Fig. 2) . Qlymph increased to 9.6±1.2 ml/15 min at 1 h and to 7.2±2.2 ml/15 min ±SE at 5 h following endotoxemia in the control endotoxin experiments, and to 8. (P > 0.05) (Fig. 3) . The lymph/plasma protein concentration decreased from 0.69±0.03 to 0.56±0.04 at 1 h and then increased to 0.82±0.04 at 5 h following endotoxemia in the control endotoxin experiments and from 0.70±0.03 to 0.61±0.04 at 1 h and to 0.79±0.06 at 5 h following endotoxemia in the platelet depletion and endotoxin experiments (P > 0.05) ( Fig. 3 ). CLP increased to 5.6±1.1 at 1 h and 6.1±2.1 ml/15 min ±SE at 5 h following endotoxemia in the control endotoxin experiments and to 5.8±0.9 at 1 h and 5.4±1.7 ml/15 min ±SE at 5 h following endotoxemia in the platelet depletion and endotoxin experiments (P > 0.05).
A At I h following endotoxemia, Cdyn decreased to 0.029±0.004 in the endotoxin control experiments and to 0.025±0.005 liter/cm H20 ±SE in the platelet depletion and endotoxin experiments (P > 0.05) (Fig. 4) . RL increased, at 1 h after endotoxemia, to 3.45±1.06 in the endotoxin control experiments and to 3.68±0.60 cm H20 -liter-' -s-' ±SE in the platelet depletion and endotoxin experiments (P > 0.05) (Fig.  4 ). FRC decreased, at 1 h after endotoxemia, to 1.045±0.126 in the control endotoxin experiments and to 0.979±0.146 liters ±SE in the platelet depletion and endotoxin experiments ........ > (P > 0.05) (Fig. 4) . SGL increased to 4.11 ± 1.70 at 1 h following X endotoxemia in the endotoxin control experiments and to 4.94±1.52 s/cm H20 ±SE in the platelet depletion and endotoxin experiments (P > 0.05) (Fig. 4) On gross at autopsy, the lungs appeared normal but the airways continued moderate amounts of sanguinous secretions. We speculate that death was secondary to respiratory failure in the animals studied with platelet depletion and endotoxin associated 9
with bloody airway secretions. The loss of the three animals between experiments in the group of sheep studied first with platelet depletion and endotoxin meant that paired data was available for analysis from only one of four of these sheep. [1, 15] , corticosteroids [4] , and granulocyte depletion [5, 6] )
have been shown to alter one or more aspect of the sheep's response to endotoxemia. These studies suggest a possible role of cyclooxygenase products of arachidonate metabolism in the pathogenesis of the early pulmonary hypertension and altered lung mechanics observed following endotoxemia (1, 15) . Platelets are a potentially rich source of cyclooxygenase products, especially thromboxanes, which may mediate these alterations C (7-1 1). Therefore, it was possible that platelet depletion would alter the sheep's response to endotoxemia. It was necessary, for these experiments, to first develop methods of depleting the sheep's platelets. Ideally, platelet depletion itself would not alter the base line values of the different variables measured. Rabbit APA were used to deplete the sheep of platelets. It was found that bolus injections of APA caused marked alterations in pulmonary hemodynamics 1 and lung mechanics similar to those observed following endotoxemia (Table I and Figs. 2 and 4 ). Since the cyclooxygenase inhibiting agent, meclofenamate, inhibits the early alterations -a observed following endotoxemia (1, 15) , the effects of meclofenamate on the sheep's response to bolus APA were also studied. Meclofenamate inhibited all but the decrease in platelet counts observed following APA administration. These studies with bolus APA help to define certain restrictions to experimental design with these antibodies. Repetitive doses of APA over many days results in a smaller and smaller response. It was found that up to three doses of bolus APA could be given within I wk with fairly reproducible responses. Since tachyphylaxis may still occur, it is necessary, as was done in these studies, to alter the order of experimentation so as to avoid systematic bias. Platelet depletion with APA did not attenuate the sheep's response to endotoxemia. There was no significant attenuation, by platelet depletion, of the alterations in pulmonary hemodynamics, lung mechanics, and lung fluid and solute exchange caused by endotoxemia ( Figs. 1-4) . Platelet depletion increased the likelihood of death following endotoxemia. The normal increase in airway secretions observed following endotoxemia became grossly bloody in the platelet-depleted sheep. Though all sheep survived for the 5 h of data acquisition following endotoxemia in the platelet depletion and endotoxin experiments, five of eight sheep died within 72 h of these experiments. All sheep survived the endotoxin control experiments. Certainly, normal circulating platelet counts are not necessary for the full expression of the sheep's response to endotoxemia.
These results are consistent with other observations with endotoxemia in the sheep and with results with glass bead microembolism (I 1) and complement activation (8) . Endotoxemia did not cause significant alterations in platelet counts (Fig. 1) , and histologically, platelets are not prominent in the pathologic changes observed following endotoxemia in the sheep (25) . Both lung lymph concentrations of TxB2 and 6-keto-PGF1,, increased significantly in the platelet depletion and endotoxin experiments, suggesting that endotoxemia causes the release of thromboxanes and prostacyclin from a source other than circulating platelets. These results are consistent with those observed with zymosan-activated complement in sheep (8) . Although platelets may be a rich source of mediators (7-1 1) and may still be pathologically important in ARDS (7) (8) (9) (10) (11) (12) (13) (14) (15) , normal circulating platelet counts are not necessary for the full expression of the sheep's response to endotoxemia.
In the unanesthetized sheep, endotoxemia has proven to be a valuable model to elucidate the mechanisms of endotoxininduced lung injury (1-7). How relevant results with platelet depletion and endotoxemia in the current series of experiments to other animal models and to ARDS in man? Sheep platelets have similarities and differences with platelets from other species and man (26) (27) (28) (29) (30) . Sheep platelets are poorly responsive to exogenous thromboxane, arachidonates, or epinephrine. Sheep platelets aggregate with collagen, thrombin, ADP, and serotonin, and do produce serotonin and thromboxane when stimulated. Sheep platelets only produce 17.5% of the thromboxane produced by human platelets when stimulated by the same dose of collagen (30) . Dog platelets are intermediate between sheep and man in their ability to produce thromboxane when stimulated (30) . These differences may account for platelet depletion attenuating the pulmonary hypertension observed in endotoxin shock in dogs (14) and the absence of any attenuation of the pulmonary hypertension following endotoxemia in the sheep ARDS model. It is apparent from this study, as well as from complement activation (8) , that other sources exist in sheep for thromboxane production than simply circulating platelets. It is also possible that cyclooxygenase products of arachidonate other than thromboxane cause the early pulmonary hypertension observed following endotoxemia and complement activation in sheep (1, 8, 15) . Platelet depletion does, for example, attenuate by >50% the increase in peak plasma TxB2 concentrations observed following cardiopulmonary bypass in sheep but does not attenuate the pulmonary hypertension (31). It is possible that platelets are more important in ARDS in man than in the lung injury caused by endotoxemia in sheep. These studies are important though since they illustrate that platelets are not necessary for the lung injury or the production of cyclooxygenase products in this model of lung injury.
In summary, bolus infusion of APA cause marked alterations in pulmonary hemodynamics and lung mechanics as well as depletion in circulating platelet counts. The alterations in pulmonary hemodynamics and lung mechanics, but not the drop in circulating platelet counts, were inhibited by the cyclooxygenase inhibiting agent, meclofenamate. It was possible, with the continuous infusion of APA, to deplete platelets without altering base-line values of the measured variables. Platelet depletion did not attenuate the sheep's response to endotoxemia or the normal increase in cyclooxygenase products observed in lung lymph following endotoxemia. Normal circulating platelet counts are not necessary for the full expression of the sheep's response to endotoxemia.
